Connect with us
Next week, Panama will start human trials of a COVID-19 vaccine developed by a German biotech company. An impressive number of 4,000 volunteers have signed to...
The first healthy volunteer received, in the Roman hospital, the vaccine designed by the biotech company Reithera of Castel Romano. The company was funded with $9.46...
Alliances are multiplying between laboratories to fight against COVID-19, following the example of the partnership announced on Wednesday, August 19th, between the pharmaceutical giant Roche and...
The Mainz-based biotech company BioNTech has recently presented the results of the capital increase. The company is developing a COVID-19 vaccine together with Pfizer, already in...
Galapagos, a Belgian biotech company, has entered the Italian market this year. The company plans to launch a new product and the first one in Italy,...
Celyad Oncology—a biotech startup creating a highly specialized treatment for relapsing multiple myeloma patients—has just had its clinical trial validated by the FDA. A major milestone...
The gigantic healthcare market, which is growing steadily, has attracted even more investors since the outbreak of the health crisis. Convinced that investments in health and...
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of $240 million in the first half...
In 2015, Nostoc closed the first round of investment worth $296,000 (€250,000) through the Social Exchange's participatory investment platform. Since then, the company has been growing...
The clinical trial, led by the Catholic University, together with other universities and the Sinovac Biotech laboratory, already has funding from the public sector, the Confederation...
 |
|
 |  |
 |
|